An in vitro study on the biocompatibility of WE magnesium alloys

被引:10
作者
Ge, Shuping [1 ]
Wang, Yi [2 ]
Tian, Jie [2 ]
Lei, Daoxi [2 ]
Yu, Qingsong [3 ]
Wang, Guixue [2 ]
机构
[1] Chongqing Univ Technol, Coll Chem & Chem Engn, Chongqing 400054, Peoples R China
[2] Chongqing Univ, Bioengn Coll, Key Lab Biorheol Sci & Technol, Minist Educ, Chongqing 400044, Peoples R China
[3] Univ Missouri, Ctr Surface Sci & Plasma Technol, Dept Mech & Aerosp Engn, Columbia, MO 65211 USA
关键词
magnesium alloys; rare earth element; biocompatibility; coagulation function; cytocompatibility; CELL PROLIFERATION; CORROSION; CHITOSAN; RELEASE; STENTS;
D O I
10.1002/jbm.b.33388
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Magnesium alloys are being actively studied for intravascular stent applications because of their good mechanical strength and biocompatibility. To rule out the high allergenicity of nickel and neurotoxicity of aluminum element, four kinds of WE magnesium alloys (where W represents the metallic element Y and E represents mixed rare earth (RE) elements; Y: 2.5, 5.0, 6.5, and 7.5 wt %; Nd: 1.0, 2.6, 2.5, and 4.2 wt %; Zr: 0.8 wt %) were chosen for in vitro investigation of their biocompatibility using cell culture. The results showed that, with the increase of rare earth elements in WE magnesium alloys, fibrinogen adsorption decreased and coagulation function was improved. It was also found that WE magnesium alloys promoted the adhesion of endothelial cells. With the increase of adhesion time, adhered cell numbers increased gradually. With 25% extracts, all the WE alloys promoted cell migration, while 100% extracts were not conducive to cell migration. Based on the above results, WE magnesium alloys 5.0WE (5.0Y-2.6Nd-0.8Zr) and 6.5WE (6.5Y-2.5Nd-0.8Zr) have better biocompatibility as compared with that with 2.5WE (2.5Y-1.0Nd-0.8Zr) and 7.5WE (7.5Y-4.2Nd-0.8Zr), and could be as the promising candidate materials for medical stent applications. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:482 / 487
页数:6
相关论文
共 34 条
[1]   Adiponectin stimulates production of nitric oxide in vascular endothelial cells [J].
Chen, H ;
Montagnani, M ;
Funahashi, T ;
Shimomura, I ;
Quon, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :45021-45026
[2]  
Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
[3]   Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents:: a prospective, non-randomised multicentre trial [J].
Erbel, Raimund ;
Di Mario, Carlo ;
Bartunek, Jozef ;
Bonnier, Johann ;
de Bruyne, Bernard ;
Eberli, Franz R. ;
Erne, Paul ;
Haude, Michael ;
Heublein, Bernd ;
Horrigan, Mark ;
Ilsley, Charles ;
Boese, Dirk ;
Koolen, Jacques ;
Luescher, Thomas F. ;
Weissman, Neil ;
Waksman, Ron .
LANCET, 2007, 369 (9576) :1869-1875
[4]   The road to bioabsorbable stents: Reaching clinical reality? [J].
Erne, P ;
Schier, M ;
Resink, TJ .
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2006, 29 (01) :11-16
[5]   Hydrolytic degradation of polyglyconate B: the relationship between degradation time, strength and molecular weight [J].
Farrar, DF ;
Gillson, RK .
BIOMATERIALS, 2002, 23 (18) :3905-3912
[6]   Cytotoxic effects of MgO nanoparticles on human umbilical vein endothelial cells in vitro [J].
Ge, S. ;
Wang, G. ;
Shen, Y. ;
Zhang, Q. ;
Jia, D. ;
Wang, H. ;
Dong, Q. ;
Yin, T. .
IET NANOBIOTECHNOLOGY, 2011, 5 (02) :36-40
[7]  
Guo BS, 1999, CHINESE RARE EARTHS, V20, P64
[8]   On the in vitro and in vivo degradation performance and biological response of new biodegradable Mg-Y-Zn alloys [J].
Haenzi, Anja C. ;
Gerber, Isabel ;
Schinhammer, Michael ;
Loeffler, Joerg F. ;
Uggowitzer, Peter J. .
ACTA BIOMATERIALIA, 2010, 6 (05) :1824-1833
[9]  
He T., 2001, Functional Polymers and New Technologies
[10]   Developments in metallic biodegradable stents [J].
Hermawan, H. ;
Dube, D. ;
Mantovani, D. .
ACTA BIOMATERIALIA, 2010, 6 (05) :1693-1697